Inventor · disambiguated record
Jane S. Lebkowski
Also filed as: LEBKOWSKI JANE · LEBKOWSKI JANE S
20 granted patents·12 pending applications·2,317 citations·filing 1990–2021
96Inventor score
Files withASTERIAS BIOTHERAPEUTICS INC7RHONE POULENC RORER PHARMA6LEBKOWSKI JANE S4APPLIED IMMUNESCIENCES2TSENG SUYI2
Top patents by PatentIndex Score
32 records- 0198US6576464B2Methods for providing differentiated stem cellsGERON CORP·Filed 2001·Granted Jun 10, 2003·148 cites·30 claims
- 0298US5173414AProduction of recombinant adeno-associated virus vectorsAPPLIED IMMUNESCIENCES·Filed 1990·Granted Dec 22, 1992·1.3k cites·9 claims
- 0396US5691176ARecombinant adeno-associated virus vector packaging cells and methods for useRHONE POULENC RORER PHARMA·Filed 1995·Granted Nov 25, 1997·193 cites·14 claims
- 0496US5354678AProduction of recombinant adeno-associated virus vectorsAPPLIED IMMUNESCIENCES·Filed 1992·Granted Oct 11, 1994·219 cites·8 claims
- 0594US5589377ARecombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Dec 31, 1996·121 cites·8 claims
- 0692US5834441AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC INC·Filed 1994·Granted Nov 10, 1998·96 cites·49 claims
- 0787US5807686APluripotential quiescent stem cell populationUNIV MINNESOTA·Filed 1995·Granted Sep 15, 1998·95 cites·8 claims
- 0887US5681731AMethod for producing recombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Oct 28, 1997·51 cites·25 claims
- 0984US10286009B2Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injuryASTERIAS BIOTHERAPEUTICS INC·Filed 2016·Granted May 14, 2019·3 cites·10 claims
- 1083US5780280ARecombinant adeno-associated virus vectorsRHONE POULENC RORER PHARMA·Filed 1995·Granted Jul 14, 1998·40 cites·12 claims
- 1182US8323966B2Differentiated pluripotent stem cell progeny depleted of extraneous phenotypesLEBKOWSKI JANE S·Filed 2010·Granted Dec 4, 2012·10 cites·8 claims
- 1277US8093049B2Differentiation of primate pluripotent stem cells to hematopoietic lineage cellsTSENG SUYI·Filed 2009·Granted Jan 10, 2012·5 cites·17 claims
- 1376US5861314AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 19, 1999·28 cites·5 claims
- 1470US9074182B2Differentiated pluripotent stem cell progeny depleted of extraneous phenotypesASTERIAS BIOTHERAPEUTICS INC·Filed 2012·Granted Jul 7, 2015·1 cites·7 claims
- 1569US5861171AAdeno-associated viral (AAV) liposomes and methods related theretoRHONE POULENC RORER PHARMA·Filed 1995·Granted Jan 19, 1999·20 cites·3 claims
- 1665US11123374B2Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injuryASTERIAS BIOTHERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·0 cites·9 claims
- 1765US9023645B2Isolated in vitro cell population comprising primate pluripotent stem cells containing a nucleic acid construct and differentiated progeny of the pluripotent stem cellsASTERIAS BIOTHERAPEUTICS INC·Filed 2013·Granted May 5, 2015·0 cites·20 claims
- 1864US6652850B1Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunityAVENTIS PHARMA INC·Filed 1996·Granted Nov 25, 2003·18 cites·27 claims
- 1961US2021379114A1Pluripotent stem cell-derived oliogodendrocyte progenitor cells for the treatment of spinal cord injuryC/O ASTERIAS BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2059US10344262B2Differentiation of primate pluripotent stem cells to hematopoietic lineage cellsASTERIAS BIOTHERAPEUTICS INC·Filed 2017·Granted Jul 9, 2019·0 cites·14 claims
- 2158US8426198B2In vitro differentiated cell and human embryonic stem cell populationGOLD JOSEPH D·Filed 2006·Granted Apr 23, 2013·0 cites·11 claims
- 2258US2003040111A1Differentiated cells suitable for human therapyFiled 2002·Application pending·0 cites
- 2354US2007292448A1Preloaded dendritic cell vaccines for treating cancerLEBKOWSKI JANE S·Filed 2007·Application pending·0 cites
- 2453US2005142121A1System for improving acceptance of tissue grafts made from embryonic stem cellsFiled 2004·Application pending·0 cites
- 2550US2006057129A1Preloaded dendritic cell vaccines for treating cancerLEBKOWSKI JANE S·Filed 2005·Application pending·0 cites
- 2650US2006063255A1Method for making dendritic cell vaccines from embryonic stem cellsLEBKOWSKI JANE S·Filed 2005·Application pending·0 cites
- 2749US2016145572A1Differentiated Pluripotent Stem Cell Progeny Depleted of Extraneous PhenotypesASTERIAS BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2846US2003211603A1Reprogramming cells for enhanced differentiation capacity using pluripotent stem cellsFiled 2001·Application pending·0 cites
- 2946US2023134801A1Mhc restricted immunogenic telomerase reverse transcriptase -specific peptides, their complex conjugates, and methods of using the sameLINEAGE CELL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3046US2012107931A1Differentiation of primate pluripotent stem cells to hematopoietic lineage cellsTSENG SUYI·Filed 2011·Application pending·0 cites
- 3137US2003095989A1Chimeric cytolytic viruses for cancer treatmentFiled 2001·Application pending·0 cites
- 3236US2019262405A1Pluripotent stem cell-derived oligodendrocyte progenitor cells for the treatment of spinal cord injuryASTERIAS BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jane S. Lebkowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →